Retraction Note to: A randomized phase II study of everolimus for advanced pancreatic neuroendocrine tumors in Chinese patients
Crossref DOI link: https://doi.org/10.1007/s12032-015-0661-4
Published Online: 2015-07-21
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yao, Jun
Wang, Jian-yao
Liu, Yi
Wang, Bin
Li, Ying-xue
Zhang, Ru
Wang, Li-Sheng
Liu, Lei
Text and Data Mining valid from 2015-07-21